List of SBIR/STTR awards granted to A&G Pharmaceutical, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to A&G Pharmaceutical, Inc. in September, 2018 for $1,101,350.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA210817-02 | Phase II | 1,101,350 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to A&G Pharmaceutical, Inc. in September, 2020 for $1,062,115.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA224718-02 | Phase II | 1,062,115 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. in September, 2018 for $159,365.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA224718-01A1 | Phase I | 159,365 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to A&G Pharmaceutical, Inc. in September, 2017 for $1,988,100.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA162629-02A1 | Phase II | 1,988,100 | September 15, 2017 | |||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. in March, 2017 for $152,589.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA210817-01A1 | Phase I | 152,589 | March 15, 2017 | |||||||
A SBIR Phase II contract was awarded to A&G Pharmaceutical, Inc. for $1,478,552.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CO140040 | Phase II | 1,478,552 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $193,879.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA162629-01A1 | Phase I | 193,879 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $199,828.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CA130074 | Phase I | 199,828 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $184,029.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI079973-01A1 | Phase I | 184,029 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $113,320.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA153800-01A1 | Phase I | 113,320 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $99,960.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA105576-01 | Phase I | 99,960 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $199,380.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120060 | Phase I | 199,380 | ||||||||
A SBIR Phase II contract was awarded to A&G Pharmaceutical, Inc. for $1,153,870.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA124179-02A2 | Phase II | 1,153,870 | ||||||||
A SBIR Phase I contract was awarded to A&G Pharmaceutical, Inc. for $120,600.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA124179-01A1 | Phase I | 120,600 | ||||||||
A SBIR Phase II contract was awarded to A&G Pharmaceutical, Inc. for $1,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201500030C-0-0-0 | Phase II | 1,000,000 |
